Acadia Pharmaceuticals (ACAD) EBT Margin Growth (5y) (2015 - 2026)
Acadia Pharmaceuticals (ACAD) EBT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Acadia Pharmaceuticals |
3.68 Bn |
2.83 Bn |
243.27 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
6,383.00 |
| Dec 31, 2025 |
6,409.00 |
| Sep 30, 2025 |
8,638.00 |
| Jun 30, 2025 |
5,311.00 |
| Mar 31, 2025 |
10,911.00 |
| Dec 31, 2024 |
11,558.00 |
| Sep 30, 2024 |
6,016.00 |
| Jun 30, 2024 |
8,097.00 |
| Mar 31, 2024 |
14,510.00 |
| Dec 31, 2023 |
12,708.00 |
| Sep 30, 2023 |
8,132.00 |
| Jun 30, 2023 |
11,433.00 |
| Mar 31, 2023 |
7,185.00 |
| Dec 31, 2022 |
12,825.00 |
| Sep 30, 2022 |
16,132.00 |
| Jun 30, 2022 |
19,505.00 |
| Mar 31, 2022 |
47,662.00 |
| Dec 31, 2021 |
61,386.00 |
| Sep 30, 2021 |
134,816.00 |
| Jun 30, 2021 |
7.35 Mn |
